Emerging, noninvasive surrogate markers of atherosclerosis.
Noninvasive surrogate markers of atherosclerosis allow the physician to identify subclinical disease before the occurrence of adverse cardiovascular events, thereby limiting the need to perform invasive diagnostic procedures. Imaging modalities, such as carotid artery ultrasound, two-dimensional echocardiography, coronary artery calcium imaging, cardiac magnetic resonance imaging, ankle-brachial indices, brachial artery reactivity testing, and epicardial coronary flow reserve measurements, provide information that may improve the predictive value of a person's risk of developing clinically significant atherosclerotic disease. Newer imaging modalities have also emerged to bring insight into the pathophysiology and treatment of atherosclerosis.
Patel
Samir N
SN
Department of Medicine, Rush University Medical Center, 1653 West Congress Parkway, Jelke 1015, Chicago, IL 60612, USA.
Rajaram
Venkataraman
V
Pandya
Sanjay
S
Fiedler
Benjamin M
BM
Bai
Charlotte J
CJ
Neems
Rachel
R
Feinstein
Matt
M
Goldin
Marshall
M
Feinstein
Steven B
SB
D001161:Arteriosclerosis / Q000175:diagnosis* / Q000517:prevention & control*; D015415:Biomarkers; D001783:Blood Flow Velocity; D001916:Brachial Artery / Q000502:physiology; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002339:Carotid Arteries / Q000473:pathology*; D002986:Clinical Trials as Topic; D003326:Coronary Circulation; D003952:Diagnostic Imaging; D004452:Echocardiography; D006801:Humans; D018810:Magnetic Resonance Angiography; D014057:Tomography, X-Ray Computed; D017539:Tunica Intima / Q000473:pathology; D017540:Tunica Media / Q000473:pathology
D015415:Biomarkers